Clinical Trials Logo

Filter by:
NCT ID: NCT04886934 Enrolling by invitation - Cardiac Disease Clinical Trials

Temporary Epicardial Pace Wire With Integrated Sensor for Continuous Postoperative Monitoring of Myocardial Function

Start date: October 25, 2021
Phase: N/A
Study type: Interventional

Transesophageal echocardiography is used to monitor cardiac wall motion at various time points during open-heart surgery. After surgery, the measurements are made at various time points by transthoracic echocardiography. The CS1 system enables continuous, direct measurement of cardiac wall motion. This is achieved through use of temporary pacemaker wires incorporating a motion detector called an accelerometer. Use of TMEs during and after open-heart surgery is part of the normal clinical routine. Continuous monitoring of cardiac wall motion during and after surgery can quickly highlight the need for medical intervention with cardiac drugs and allow very early detection of potentially serious complications leading to abnormal cardiac wall motion. Cardiac wall motion activity registered by the CS1 system and echocardiography at specific time points during and after surgery will be analyzed to see how well they compare.

NCT ID: NCT04885036 Active, not recruiting - Mental Health Issue Clinical Trials

Effectiveness of Emotion Focused Skills Training (EFST)

Start date: December 8, 2021
Phase: N/A
Study type: Interventional

Comparing the effectivity of an EFST parent supervision intervention against Treatment As Usual in an outpatient specialist health care clinics Family unit.

NCT ID: NCT04879875 Completed - Ischemia Clinical Trials

New Method for Real-time Detection of Tissue Ischemia (ISCALERT)

ISCALERT
Start date: September 1, 2021
Phase: N/A
Study type: Interventional

This is a prospective, single arm, open, single centre clinical investigation designed to examine the feasibility and safety of the IscAlertâ„¢ device in patients scheduled for limb (arm/leg) surgery with tourniquet. IscAlert is measuring CO2 in muscular and subcutaneous tissue. IscAlert is inserted into normal muscle and subcutaneous tissue in ischemic (operated limb with a tourniquet) and non-ischemic limb (non-operated limb).After the tourniquet is inflated, ischemia develops in the muscles and subcutaneous tissue. This will result in an increase in CO2, which will be detected by the sensors on the operated extremity, while the sensors on the non-operated will show normal values. After releasing the tourniquet cuff, the muscle will be reperfused and the CO2 level is expected to decrease into normal levels. 50 number of patients will be enrolled to undergo the procedures. The IscAlert will be removed from the patient before the patient is discharged from the operating room, but in 25 of the patients, IscAlertâ„¢ will be inserted for 72 hours in the operated extremity after the end of surgery. After this, the sensors are removed. 250 Devices is planned to be used in this clinical study.

NCT ID: NCT04876391 Completed - Clinical trials for Hidradenitis Suppurativa

A Study Investigating Long-term Treatment With Spesolimab in People With a Skin Disease Called Hidradenitis Suppurativa Who Completed a Previous Clinical Trial

Start date: July 27, 2021
Phase: Phase 2
Study type: Interventional

This study is open to adults with hidradenitis suppurativa who took part in a previous clinical study of a medicine called spesolimab. Participants who completed treatment can join this study. The purpose of this study is to find out how safe spesolimab is and whether it helps people with hidradenitis suppurativa in the long-term. Participants are in this study for about 2 years and 4 months. For 2 years, participants visit the study site every 2 weeks to get spesolimab injections under the skin. At study visits, doctors check the severity of participants' hidradenitis suppurativa and collect information on any health problems of the participants.

NCT ID: NCT04870866 Active, not recruiting - Clinical trials for Ataxia Telangiectasia

NAD Supplementation to Prevent Progressive Neurological Disease in Ataxia Telangiectasia

Start date: June 5, 2019
Phase: Phase 2
Study type: Interventional

The study investigates the effect of dietary supplementation of nicotinamide ribonucleoside (NR) in children with ataxia telangiectasia (AT), with main focus on neurological symptoms.

NCT ID: NCT04870619 Completed - Stroke Clinical Trials

FIRST-Oslo Long-term Follow-up

Start date: June 20, 2021
Phase:
Study type: Observational

The study aims to describe the functional level of the patients who received high intensity gait training during inpatient stroke rehabilitation at discharge, three, six and twelve months after stroke. These data will determine if the observed gains from the high-intensity gait training are retained after discharge from inpatient rehabilitation.

NCT ID: NCT04870151 Recruiting - Hip Fractures Clinical Trials

Anterolateral Versus Direct Lateral Approach in Hemiarthroplasty for Hip Fracture

Start date: June 1, 2021
Phase: N/A
Study type: Interventional

Patients with dislocated hip fractures are randomised to cemented hemiarthroplasty with an anterolateral approach or a direct lateral approach.

NCT ID: NCT04868305 Recruiting - Hip Fractures Clinical Trials

Intramedullary Nail Versus Hip Arthroplasty in Unstable Trochanteric Hip Fractures

TUFHIPRCT
Start date: October 12, 2021
Phase: N/A
Study type: Interventional

A hip fracture is a large burden to the patient with increased mortality, pain and increased need for daily assistance. Trochanteric fractures of the femur (FTF) represents about 35% of the hip fractures. Today FTFs are mainly treated with internal fixation using sliding hips screws (SHS) or intramedullary nail (IMN), whilst hip arthroplasty (THA/HA) is rarely used. Despite advances in the design of the internal fixation implants there is a high failure rate, in particular in cases of FTFs classified as unstable fractures. Since the introduction of hip arthroplasty in femoral neck fractures there has been a reduction in complication rates, early mobilization and shorter hospital stays. The primary objective of this project is to investigate if treatment with hip arthroplasty in unstable FTFs will increase the postoperative mobility, give a better general health outcome for the patient, better quality of life and reduce re-operation rate for the patients compared to those operated with the traditional IMN.

NCT ID: NCT04866589 Completed - Covid19 Clinical Trials

COVID-19: The Effectiveness of Free Face Mask Distribution

Start date: May 3, 2021
Phase: N/A
Study type: Interventional

The investigators will carry out a randomised trial of free face mask distribution in Stovner District, Oslo, Norway. Ten grocery stores will serve as study sites. Over three weeks the stores will be randomised daily to having "corona hosts" outside their entrance, handing out face masks to customers. The investigators will compare the proportion of customers who wear face masks as they enter the store in stores with or without face mask distribution.

NCT ID: NCT04864353 Recruiting - Clinical trials for Cognitive Impairment

Internet-delivered Intervention Targeting Residual Cognitive Symptoms After Major Depressive Disorder

RestDep
Start date: April 26, 2021
Phase: N/A
Study type: Interventional

Background: Cognitive impairment and difficulties are frequently observed in individuals suffering from major depressive disorder. These impairments and difficulties can persist into remission as residual cognitive symptoms. Consequently affecting daily life functioning and quality of life for those affected. Few scalable interventions have targeted these symptoms and measured long-term clinical effects such as depression relapse.